Related Experiment Video

Updated: Jul 19, 2026

Implementation of a Permeable Membrane Insert-based Infection System to Study the Effects of Secreted Bacterial Toxins on Mammalian Host Cells
09:25

Implementation of a Permeable Membrane Insert-based Infection System to Study the Effects of Secreted Bacterial Toxins on Mammalian Host Cells

Published on: August 19, 2016

Protein kinase G from pathogenic mycobacteria promotes survival within macrophages

Anne Walburger1, Anil Koul, Giorgio Ferrari

  • 1Biozentrum, University of Basel, Klingelbergstr. 50/70, CH-4056 Basel, Switzerland.

Science (New York, N.Y.)
|May 25, 2004
PubMed

Insights

Pathogenic mycobacteria evade immune cells by secreting protein kinase G, which blocks lysosome fusion. Inhibiting this kinase causes mycobacteria to be destroyed within macrophages, offering a new treatment target.

Area of Science:

  • * Cellular microbiology
  • * Molecular biology
  • * Immunology

Background:

  • * Pathogenic mycobacteria survive inside host macrophages by preventing their delivery to lysosomes.
  • * Understanding the mechanisms of intracellular survival is crucial for developing effective treatments.

Purpose of the Study:

  • * To investigate the role of serine/threonine protein kinase G in mycobacterial intracellular survival.
  • * To identify protein kinase G as a potential therapeutic target for mycobacterial infections.

Main Methods:

  • * Studied the secretion and function of protein kinase G in macrophage phagosomes.
  • * Utilized gene disruption and chemical inhibition to inactivate protein kinase G.
  • * Assessed the localization and viability of mycobacteria within infected macrophages.

Main Results:

  • * Secreted protein kinase G inhibits phagosome-lysosome fusion, enabling mycobacterial survival.
  • * Inactivation of protein kinase G leads to lysosomal targeting and cell death of mycobacteria.
  • * Pathogenic mycobacteria employ eukaryotic-like signaling to manipulate host cell pathways.

Conclusions:

  • * Protein kinase G is essential for the intracellular survival of pathogenic mycobacteria.
  • * Inhibiting protein kinase G represents a promising strategy for controlling mycobacterial infections.
  • * Mycobacteria utilize host-like signaling pathways to evade immune responses.

More Related Videos

Development and Identification of a Novel Subpopulation of Human Neutrophil-derived Giant Phagocytes In Vitro10:05

Development and Identification of a Novel Subpopulation of Human Neutrophil-derived Giant Phagocytes In Vitro

Published on: January 25, 2017

Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds06:36

Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds

Published on: September 8, 2021

Related Concept Videos

Defense Mechanism Against Infection01:26

Defense Mechanism Against Infection

Natural flora, body system defenses, and inflammation are natural barriers of the body against infectious agents regardless of previous exposure. Normal floras of the human body refer to the microbial population that colonizes the skin and mucous membranes.
In addition, many body organ systems have unique defenses against infection. The skin is an intact, multilayered surface preventing invasion by microorganisms unless impaired. Mucous membranes lining the mouth, nose, and eyelids are barriers...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Stringent Response in E. coli01:23

Stringent Response in E. coli

Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...
Bacterial Toxins01:12

Bacterial Toxins

Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...